RT Journal Article
SR Electronic
T1 736 A phase 1/2 open-label, dose-escalation study of ST-067, a decoy-resistant IL-18 cytokine, given as a monotherapy and with pembrolizumab in advanced solid tumor malignancies
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A829
OP A829
DO 10.1136/jitc-2023-SITC2023.0736
VO 11
IS Suppl 1
A1 Moser, Justin C
A1 Sullivan, Ryan
A1 Taylor, Matthew H
A1 Puzanov, Igor
A1 Falchook, Gerald S
A1 Sznol, Mario
A1 Paton, Virginia E
A1 Chonzi, David
A1 Garofalo, Brage
A1 Sonnemann, Mark
A1 Uppal, Hirdesh
A1 Barton, Jeremy
A1 McQueen, Beatrice Y
A1 Ring, Aaron M
A1 Kluger, Harriet
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A829.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.